Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, the thigh is one of three licensed injection sites for Mounjaro (tirzepatide). Many people find the leg straightforward to use, especially when injecting alone. The KwikPen works the same way on the thigh as it does on the abdomen or upper arm, and rotating between all three sites is part of good injection technique. These are prescription-only medicines; a clinical assessment by a prescriber determines whether Mounjaro is appropriate for you personally. If you have questions about your own injection routine, your prescriber or the Patient Information Leaflet is the right place to start.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A surprisingly common concern among people starting Mounjaro is that using the leg is somehow less effective or more risky than the abdomen. It isn't. The Mounjaro SmPC — the prescribing document reviewed and approved by UK regulators — lists the outer thigh alongside the abdomen and upper arm as suitable sites for subcutaneous injection. There is no clinical evidence that one approved site produces meaningfully different absorption compared to another in the context of tirzepatide. The worry often stems from experience with older injectable medicines, where site selection mattered more. With Mounjaro's KwikPen, the priority is using an approved site correctly, not picking the 'best' one.
Some people do find one site more comfortable than the others. That is normal and personal. If the thigh consistently feels less comfortable for you, your prescriber can discuss your technique or whether another site suits you better. The key word there is 'consistently', mild pinching at any site is common and usually nothing more than the skin's response to the needle.
For anyone getting started with Mounjaro, the tirzepatide overview covers the basics of how the medicine works and what the first few weeks typically involve.
The outer thigh is the recommended area, the front-outer portion of the upper thigh, roughly the part you'd touch if you rested a relaxed hand on your leg. A few practical points make the experience easier. Let the pen come to room temperature before injecting; a cold pen straight from the fridge tends to sting more. Sitting with your leg relaxed rather than tensed also helps the needle reach subcutaneous tissue without discomfort. Clean the skin first with an alcohol swab and let it dry completely before injecting, wet skin makes the sting worse.
Pinching the skin gently before pressing the pen is sometimes useful on thinner areas of the thigh, though for most people the KwikPen's automatic depth is appropriate without it. Once the injection is done, press the pen gently against the skin for the full recommended time shown in the instructions before removing it, this helps ensure the full dose is delivered. Never rub the area afterwards.
If you have noticed any soreness, bruising or skin changes around your usual thigh site, the information on leg pain and Mounjaro covers the range of causes and when a reaction warrants medical attention.
Staying on the same patch of thigh week after week is one of the more common mistakes people make. Repeated injections into exactly the same spot can cause lipohypertrophy (a hardening or thickening of the tissue under the skin) and that hardened tissue absorbs the medicine less reliably. Rotating across the available sites and varying the spot within each site avoids this.
A simple rotation that many people settle into: abdomen one week, thigh the next, upper arm the week after, then back to the abdomen. Others prefer to stay on the thigh and move the exact position systematically, a few centimetres each time. Either approach is fine. What matters is that you don't inject into an area that is still tender, bruised, hard, or shows any skin change from a previous injection. The same principle applies if you're using the left and right thigh on alternate weeks.
Thinking about where you'll be on any given week can help. Some patients find it easier to use the thigh when travelling, a desk or seat lets you reach comfortably without exposing the abdomen. Others use the abdomen at home and keep the thigh as a practical option when they're out. Small habits make a real difference to long-term comfort.
For a fuller picture of what Mounjaro involves, including eligibility and how private treatment works, the Mounjaro information page is a good reference. Details on private treatment costs, if that is part of your research, are on the Mounjaro prices page.
Most reactions at the thigh injection site are minor: brief redness, a small bump, or mild tenderness that settles within a day or two. These are not reasons to stop injecting, change sites permanently, or contact a prescriber urgently. However, some signs do need attention.
Contact your prescriber or GP if you notice a site reaction that spreads, becomes warm, or does not improve after several days, this may indicate localised infection. Persistent, deepening bruising is also worth mentioning. If you develop pain that runs down the leg rather than staying at the skin surface, or muscle cramps that are new and unexplained, read about whether Mounjaro can cause leg pain and speak to your prescriber before your next dose.
In rare cases, people experience restless leg symptoms or unusual sensations during treatment. These are worth recording and discussing at your next clinical review rather than ignoring. Mounjaro carries a Black Triangle (▼) designation, meaning the MHRA actively collects post-market safety data; if you experience something unexpected you can report it directly via the Yellow Card scheme.
If you have not yet started treatment and want to understand whether Mounjaro is clinically suitable for you, our prescribers carry out a same-day review of every consultation. You can start your free consultation at any point, with no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.